A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

Clinical trial NCT07705555 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07705555
Sponsor: Merck Sharp & Dohme LLC
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Retinopathy Macular Edema

Start date: 2026-08-28
Primary completion: 2028-10-31
Enrollment: 960

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.